IPR & Healthcare
Glossary
IP & Gelatin Glossary
Two tables: IP fundamentals in healthcare (the discovery layer), and gelatin-specific technical and regulatory terms. All definitions are written for reference, not legal advice.
IP fundamentals in healthcare
Core intellectual property concepts as they apply to pharmaceutical and healthcare products.
| Term | Definition |
|---|---|
| Utility patent | Protects how a product or process works, e.g. a specific gelatin capsule formulation or manufacturing process. Lasts 20 years from filing in the US. |
| Formulation patent | A patent on a specific mixture or composition (e.g. a modified-guar-gum soft gelatin capsule dosage form) rather than the base ingredient itself. |
| Trademark | Protects brand names, logos, and product names (e.g. a capsule shell brand name); indefinite as long as it is used and renewed. |
| Trade secret | Protects confidential processes or formulations that are not disclosed publicly, common for manufacturing know-how that is hard to reverse-engineer, like exact gelling/bloom-strength processing steps. |
| Regulatory exclusivity | Market protection granted by a regulator, separate from a patent, e.g. FDA exclusivity periods under Hatch-Waxman for new drugs, or orphan drug exclusivity. |
| Hatch-Waxman Act | The 1984 US law (Drug Price Competition and Patent Term Restoration Act) that created the modern generic drug approval pathway and patent term restoration for brand-name drugs. |
| Patent Term Extension (PTE) | Restores part of a patent's life lost to FDA review time, capped at 5 years and 14 years total post-approval protection. |
| BLA (Biologics License Application) | The FDA approval pathway for biologic products, governed separately from small-molecule drugs; relevant if gelatin-based products are classified as biologics (e.g. certain wound-care or drug-delivery matrices). |
| Excipient | An inactive ingredient (like gelatin in a capsule shell) that carries or delivers the active drug, regulated differently than the active ingredient itself. |
| GRAS (Generally Recognized As Safe) | An FDA food-safety designation; many gelatin grades qualify, which matters for supplements and food-adjacent health products. |
| Inactive Ingredient Database (IID) | FDA's database of excipients (including gelatin types) already approved in an FDA product at a given exposure level; a common reference point in formulation IP strategy. |
Gelatin-specific technical and regulatory terms
Terms specific to gelatin as a pharmaceutical excipient — sourcing, processing, and regulatory context.
| Term | Definition |
|---|---|
| Bovine / porcine / fish gelatin | Gelatin is sourced from cattle, pigs, or fish collagen; the source affects sourcing regulation, religious/dietary compliance (halal, kosher), and BSE/TSE risk profile. |
| BSE / TSE (Bovine Spongiform Encephalopathy / Transmissible Spongiform Encephalopathy) | The "mad cow disease" risk category that drives strict sourcing and certification rules for bovine-derived gelatin used in pharma and food, including FDA rules on cattle materials in human food and cosmetics. |
| Pharmacopeial standard (USP-NF, Ph. Eur.) | Gelatin used in drugs must meet pharmacopeial monographs (US Pharmacopeia-National Formulary, European Pharmacopoeia) for purity, bloom strength, and identity; harmonized internationally through bodies like the Pharmacopeial Discussion Group (PDG). |
| Bloom strength | A measurement of gelatin's gel strength/firmness; a key formulation variable that patents and trade secrets often center on for capsule stability. |
| Hard capsule vs. soft gelatin (softgel) capsule | Two different manufacturing processes and IP landscapes: hard capsules are two-piece shells filled with powder/pellets; softgels are one-piece, seamless, filled with liquid/semi-solid. Each has its own patent literature (e.g. US 5,985,321 on soft gelatin capsule manufacture). |
| GMP (Good Manufacturing Practice) | The quality-system standard gelatin producers must follow to supply pharmaceutical-grade material; a prerequisite for supplying regulated healthcare products, separate from IP protection itself. |
| Collagen peptides | Hydrolyzed gelatin, broken down further for nutraceutical/health applications; a distinct product category and IP landscape from capsule-grade gelatin. |
| Halal / Kosher certification | Religious dietary certifications that constrain sourcing and processing; a commercial/regulatory factor healthcare product makers weigh alongside patent and trademark strategy. |
Continue to the case studies for a real, sourced example of these concepts in practice.
Case studies